Filter Results
:
(597)
Show Results For
-
All HBS Web
(1,032)
- People (4)
- News (254)
- Research (597)
- Events (7)
- Multimedia (25)
- Faculty Publications (384)
Show Results For
-
All HBS Web
(1,032)
- People (4)
- News (254)
- Research (597)
- Events (7)
- Multimedia (25)
- Faculty Publications (384)
Sort by
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
at the US Food and Drug Administration and the Centers for Medicare and Medicaid Services. The pandemic has made it clear that this must change. Richard Hamermesh (@RHamermesh) is a Baker Foundation Professor of Management Practice and...
View Details
Keywords:
by Danielle Kost
- 04 Aug 2009
- First Look
First Look: August 4
to second-line drug regimens, 3.8% had died, and only one patient had been lost to follow up. A costing analysis done by the Clinton HIV/AIDS Initiative suggested that the model could feasibly be spread to other districts. Dr. Agnes...
View Details
Keywords:
Martha Lagace
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is...
View Details
- 23 May 2019
- Book
These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems
In 1908, Harvard Business School’s first dean, Edwin Francis Gay, welcomed the School’s inaugural class of 59 students by saying that HBS was challenged with encouraging its students to have the “intellectual respect for business as a profession, with the social...
View Details
- 15 Apr 2014
- First Look
First Look: April 15
from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was marketed as a diagnostic and preventative tool and that it was subject to...
View Details
Keywords:
Sean Silverthorne
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
Howard, Sara J. Singer, and Amy C. Edmondson Abstract— For too long, the worlds of business and health have been mired in a checkered, sometimes contentious, history. Millions of deaths worldwide can be attributed to risk factors including tobacco use, alcohol and...
View Details
Keywords:
Dina Gerdeman
- 29 Oct 2013
- First Look
First Look: October 29
scheme, more extensive than any previously revealed in professional sports history." Until that moment with Oprah, Armstrong had consistently and strenuously denied using performance enhancing drugs (PEDs), blood transfusions, or...
View Details
Keywords:
Sean Silverthorne
- 14 Dec 2010
- First Look
First Look: Dec. 14
511-075 By 2009, Hikma Pharmaceuticals operated 13 manufacturing plants in 8 countries of which 5 were approved by the U.S. Food and Drug Administration. Hikma tracked its sales revenues over the period to show from where the largest...
View Details
Keywords:
Sean Silverthorne
- 23 Aug 2016
- First Look
August 23, 2016
particular, we examine how individuals’ prior experiences and the experiences of those around them alter their belief perseverance in operational decisions after the revelation of negative news. We draw on an exogenous announcement of negative news by the Food and...
View Details
Keywords:
Sean Silverthorne
- 25 Feb 2014
- First Look
First Look: February 25
is based in Massachusetts and lists in London on AIM. Products are genetically modified fast-growing salmon for fish farmers and disease-prevention drugs and diagnostic kits for farmed shrimp. Purchase this case:...
View Details
Keywords:
Sean Silverthorne
- 18 Apr 2018
- First Look
First Look at New Research and Ideas, April 18, 2018
The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule”...
View Details
Keywords:
Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
with revenue expectations of $1 billion in 2015. At the time of the acquisition, AbbVie received more than 60% of its sales from the drug Humira, a biologic agent used to treat several autoimmune diseases and malignancies. However, Humira...
View Details
Keywords:
Sean Silverthorne
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase...
View Details
Keywords:
Martha Lagace
- 12 May 2009
- First Look
First Look: May 12, 2009
their practices. Sermo earns revenue by charging clients who would value early information regarding the effectiveness of new drugs and medical devices-investment managers, pharmaceutical companies, and regulatory authorities. Clients...
View Details
Keywords:
Martha Lagace
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
Although Novartis would improve its position in oncology by acquiring GSK’s promising drug portfolio, it had to sell its vaccines and animal health businesses, while giving up control of the over-the-counter (OTC) business. Jimenez and...
View Details
Keywords:
Carmen Nobel
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
The book Capitalism at Risk first appeared in 2011. The problems it identified with social inequality, global trade strife, and environmental degradation have only accelerated by 2020. The new edition of Capitalism at Risk, subtitled How Business Can Lead, is expanded...
View Details
Keywords:
by Martha Lagace
- 22 Mar 2011
- First Look
First Look: March 22
successful convenience foods business to more countries. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/511070-PDF-ENG PureCircle David E. Bell and Aldo SesiaHarvard Business School Case 510-032 In December 2008, the U.S. Food and View Details
Keywords:
Sean Silverthorne
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts that gains from DTCA, M&E,...
View Details
Keywords:
Sean Silverthorne
- 18 Sep 2007
- First Look
First Look: September 18, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=907025 NatuRi Corporation Harvard Business School Case 807-027 NatuRi Corporation was a start up, founded in 2005, aiming to manufacture a cholesterol-lowering drug made from...
View Details
Keywords:
Martha Lagace
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
mother gave me a copy of The Jungle by Upton Sinclair. I was very struck by that book. I find the writing, in retrospect, really wretched, but the kind of passion that said, "Here is an awful system," was pivotal in getting food and View Details